BioSafe Technologies Founder Wins 3 Stevie® Awards
BioSafe Technologies Founder Wins 3 Stevie® Awards 2017 Stevie® Awards For Women in Business The 14th edition of the world's top honors for female entrepreneurs, executives, employees and the organizations they run were presented on November 17, 2017 at the Marriott Marquis Hotel in New York City. More than 550 [read more]
XIM Bank Case Study: Got Lice?
XIM Bank Case Study: Got Lice?January 23, 2018 Elizabeth Thomas, Business Development Specialist, Office of Small Business Well we hope not, but if so, BioSafe Technologies of Denison, Texas, has the shampoo for you. Founded in 2000, BioSafe products are the result of a research project seeking non-toxic methods for controlling [read more]
Texas Company Removing Lice from Children’s Hair Worldwide
Texas Company Removing Lice from Children's Hair Worldwide March 16, 2020 Aisac Accad, Office of Communications, EXIM Bank Every March, Women’s History Month recognizes the accomplishments and contributions of women to society, culture, and history. From space exploration to the performing arts, women have impacted every sector and field. EXIM [read more]
Review on Antimicrobial Resistance
Review on Antimicrobial Resistance (AMR) Wellcome Trust & UK Department of Health The Review on Antimicrobial Resistance (AMR), was commissioned in July 2014 by the UK Prime Minister, who asked economist Jim O’Neill to analyse the global problem of rising drug resistance and propose concrete actions to tackle it internationally. [read more]
Antimicrobial Resistance
Antimicrobial Resistance 20 August 2017 | WHO News Release | Geneva Many of the medical breakthroughs of the last century could be lost through the spread of antimicrobial resistance. Previously curable infectious diseases may become untreatable and spread throughout the world. This has already started to happen.The report “Antimicrobial resistance: global [read more]
Critical Assessment of Incentive Strategies for Development of Novel Antibiotics
A Critical Assessment of Incentive Strategies for Development of Novel Antibiotics 31 October 2014 LSE Health, London School of Economics and Political Science Matthew Renwick, David Brogan, & Elias Mossialos1 In recent years, a concern has emerged in the public health arena regarding the deadly combination of increasing antimicrobial resistance [read more]